Updates in prostate …

Recent Advances in Prostate Cancer. New FDA-approved therapeutics 1- Darolutamide (Nubeqa®, Bayer Healthcare Pharmaceuticals Inc.): Expanding Options in mHSPC. Darolutamide is a recently FDA-approved treatment for metastatic hormone-sensitive prostate... Read More

Saudi GU Working Gro…

Saudi Gu Working Event The inaugural Saudi Genitourinary (GU) Working Group preparatory meeting gathered a distinguished panel of healthcare experts from the fields of urology, uro-oncology, and medical oncology.... Read More